CUSIP 004225108 · who reports it, how much, and how much it matters to them
32 of the 720 hedge fund managers we track reported shares of Acadia Pharmaceuticals Inc (Nasdaq: ACAD) on Form 13F for 30 June 2026. Between them they reported USD 1.8bn. The largest position belongs to Baker Bros. Advisors, at USD 1.1bn. The manager with the most riding on it is Palo Alto Investors, where it is 10.0% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Baker Bros. Advisors2 funds on PPLI.com | USD 1.1bn | 5.4% |
| 2 | RTW Investments2 funds on PPLI.com | USD 181m | 1.5% |
| 3 | Palo Alto Investors6 funds on PPLI.com | USD 72m | 10.0% |
| 4 | POINT72 Asset Management17 funds on PPLI.com | USD 62m | 0.1% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 55m | 0.0% |
| 6 | Marshall Wace LLP84 funds on PPLI.com | USD 45m | 0.0% |
| 7 | D. E. Shaw & Co.15 funds on PPLI.com | USD 43m | 0.0% |
| 8 | Braidwell12 funds on PPLI.com | USD 42m | 1.5% |
| 9 | Artisan Partners1 fund on PPLI.com | USD 34m | 0.1% |
| 10 | Renaissance Technologies13 funds on PPLI.com | USD 32m | 0.0% |
| 11 | Two Sigma Investments35 funds on PPLI.com | USD 23m | 0.0% |
| 12 | Millennium Management6 funds on PPLI.com | USD 15m | 0.0% |
| 13 | Adage Capital Management1 fund on PPLI.com | USD 13m | 0.0% |
| 14 | Hudson Bay Capital Management8 funds on PPLI.com | USD 12m | 0.0% |
| 15 | Balyasny Asset Management25 funds on PPLI.com | USD 9.8m | 0.0% |
| 16 | Sphera Funds Management1 fund on PPLI.com | USD 9m | 1.2% |
| 17 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 7.2m | 0.0% |
| 18 | Edgestream Partners5 funds on PPLI.com | USD 7.2m | 0.2% |
| 19 | Logos Global Management1 fund on PPLI.com | USD 6.3m | 0.3% |
| 20 | Squarepoint Ops7 funds on PPLI.com | USD 3.5m | 0.0% |
| 21 | Orbimed Advisors1 fund on PPLI.com | USD 3.5m | 0.1% |
| 22 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 2.1m | 0.1% |
| 23 | Verdad Advisers6 funds on PPLI.com | USD 2.1m | 2.0% |
| 24 | Freestone Grove Partners1 fund on PPLI.com | USD 1.8m | 0.0% |
| 25 | Bridgewater Associates45 funds on PPLI.com | USD 1.3m | 0.0% |
| 26 | The Quarry1 fund on PPLI.com | USD 1.3m | 0.1% |
| 27 | Capstone Investment Advisors25 funds on PPLI.com | USD 467,000 | 0.0% |
| 28 | Boothbay Fund Management2 funds on PPLI.com | USD 435,000 | 0.0% |
| 29 | Entrypoint Capital1 fund on PPLI.com | USD 324,000 | 0.1% |
| 30 | Diametric Capital2 funds on PPLI.com | USD 308,000 | 0.0% |
| 31 | Graticule Asia Macro Advisors8 funds on PPLI.com | USD 22,492 | 0.0% |
| 32 | Persistent Asset Partners10 funds on PPLI.com | USD 18,090 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Palo Alto Investors | USD 72m | 10.0% |
| 2 | Baker Bros. Advisors | USD 1.1bn | 5.4% |
| 3 | Verdad Advisers | USD 2.1m | 2.0% |
| 4 | RTW Investments | USD 181m | 1.5% |
| 5 | Braidwell | USD 42m | 1.5% |
| 6 | Sphera Funds Management | USD 9m | 1.2% |
| 7 | Logos Global Management | USD 6.3m | 0.3% |
| 8 | Edgestream Partners | USD 7.2m | 0.2% |
| 9 | Campbell & Company Investment Adviser | USD 2.1m | 0.1% |
| 10 | The Quarry | USD 1.3m | 0.1% |
Acadia Pharmaceuticals Inc trades under the symbol ACAD on the Nasdaq. Its CUSIP, the code used on Form 13F, is 004225108.
32 of the 720 hedge fund managers PPLI.com tracks reported Acadia Pharmaceuticals Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Baker Bros. Advisors (USD 1.1bn), RTW Investments (USD 181m), Palo Alto Investors (USD 72m), POINT72 Asset Management (USD 62m) and Citadel Advisors (USD 55m).
32 managers in our coverage reported it, and between them they run 413 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Palo Alto Investors, where the position was 10.0% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Acadia Pharmaceuticals Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.